Global X Genomics & Biotechnology ETF (GNOM)

Assets	$52.35M
Expense Ratio	0.50%
PE Ratio	n/a
Shares Out	1.12M
Dividend (ttm)	$0.62
Dividend Yield	1.34%
Ex-Dividend Date	Dec 30, 2025
Payout Frequency	n/a
Payout Ratio	n/a

Volume	3,046
Open	46.54
Previous Close	46.36
Day's Range	46.54 - 46.80
52-Week Low	30.32
52-Week High	51.42
Beta	1.19
Holdings	52
Inception Date	Apr 5, 2019

About GNOM

Fund Home Page

The Global X Genomics & Biotechnology ETF (GNOM) is an exchange-traded fund that is based on the Solactive Genomics index. The fund tracks an index of global biotech equities, selected and weighted by market cap. GNOM was launched on Apr 5, 2019 and is issued by Global X.

• Asset Class: Equity
• Category: Health
• Stock Exchange: NASDAQ
• Ticker Symbol: GNOM
• ETF Provider: Global X
• Index Tracked: Solactive Genomics Index

Top 10 Holdings

42.87% of assets

Name	Symbol	Weight
Guardant Health, Inc.	GH	5.47%
Legend Biotech Corporation	LEGN	4.66%
Illumina, Inc.	ILMN	4.55%
Praxis Precision Medicines, Inc.	PRAX	4.19%
Arrowhead Pharmaceuticals, Inc.	ARWR	4.17%
BioMarin Pharmaceutical Inc.	BMRN	4.11%
Vertex Pharmaceuticals Incorporated	VRTX	4.09%
Natera, Inc.	NTRA	4.03%
Twist Bioscience Corporation	TWST	3.83%
Veracyte, Inc.	VCYT	3.77%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 30, 2025	$0.59121	Jan 7, 2026
Jun 27, 2025	$0.03312	Jul 7, 2025
Dec 30, 2021	$0.02603	Jan 7, 2022
Dec 30, 2020	$0.12961	Jan 8, 2021

Performance

GNOM had a total return of 53.59% in the past year, including dividends. Since the fund's inception, the average annual return has been -3.57%.